Pharma: Clinic Roundup
• CSL Behring, of King of Prussia, Pa., reported data from a single-arm, open-label study showing that Privigen (immune globulin intravenous [human], 10 percent liquid), an intravenous immunoglobulin (IVIG), may lead to improvement in function in patients with chronic inflammatory demyelinating polyneuropathy.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST